NYSE Updates Roche to halt lung-cancer drug trial after disappointing data By Admin July 4, 2024 0 29 Share FacebookTwitterPinterestWhatsApp Must read Scientists Haven’t ‘Saved’ the Ozone Layer – Watts Up With That? November 14, 2024 Republicans clinch control of House, setting stage for quicker action on extending tax cuts November 14, 2024 Quincy Jones’ Cause of Death Confirmed November 14, 2024 A crumbling system of trade rules awaits Trump’s wrecking ball November 14, 2024 Adminhttps://newschatspot.com Roche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals. Share FacebookTwitterPinterestWhatsApp Previous articleDollar on defensive after soft data, battered yen under watch By ReutersNext articleSister Wives: Christine Pays Tribute to Kody During Family Reunion Trip More articles Republicans clinch control of House, setting stage for quicker action on extending tax cuts November 14, 2024 Australia employment rises 15,900 in Oct, jobless holds at 4.1% By Reuters November 14, 2024 Americans’ $1 trillion credit-card debt problem is inching in the right direction as inflation eases November 13, 2024 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment. Latest article Scientists Haven’t ‘Saved’ the Ozone Layer – Watts Up With That? November 14, 2024 Republicans clinch control of House, setting stage for quicker action on extending tax cuts November 14, 2024 Quincy Jones’ Cause of Death Confirmed November 14, 2024 A crumbling system of trade rules awaits Trump’s wrecking ball November 14, 2024 Swelling sends QB J.J. McCarthy into second knee surgery November 14, 2024
